Comparison of glycated albumin and hemoglobin A1c levels in diabetic subjects on hemodialysis

Peacock, T.P., Shihabi, Z.K., Bleyer, A.J., Dolbare, E.L., Byers, J.R., Knovich, M.A., Calles-Escandon, J., Russell, G.B. +1 more·2008·Kidney International
DOI 10.1038/ki.2008.25

Cited by (321)

Items 101–200 of 321

  1. Comparison of the Elecsys PTH(1–84) assay with four contemporary second generation intact PTH assays and association with other biomarkers in chronic kidney disease patients
    Karen M. L. Tan, Lizhen Ong, Sunil Kumar Sethi, Sharon Saw · 2013 · Clinical Biochemistry
  2. CNDP1, NOS3, and MnSOD Polymorphisms as Risk Factors for Diabetic Nephropathy among Type 2 Diabetic Patients in Malaysia
    Mohd Jokha Yahya, Patimah Ismail, Norshariza Nordin, Abdah Md Akim, Wan Shaariah Md Yusuf, Noor Lita Adam, Nurul Fasihah Zulkifli · 2019 · Journal of Nutrition and Metabolism
  3. Glycated Albumin, Not Hemoglobin A1c, Predicts Cardiovascular Hospitalization and Length of Stay in Diabetic Patients on Dialysis
    Mariana Murea, Timothy H. Moran, Gregory B. Russell, Zak K. Shihabi, Joyce R. Byers, Lilian Andries, Anthony J. Bleyer, Barry I. Freedman · 2012 · American Journal of Nephrology
  4. Glycemic control and survival in peritoneal dialysis patients with diabetes: A 2-year nationwide cohort study
    Masanori Abe, Takayuki Hamano, Junichi Hoshino, Atsushi Wada, Shigeru Nakai, Ikuto Masakane · 2019 · Scientific Reports
  5. Immobilization-Free Electrochemical Sensor Coupled with a Graphene-Oxide-Based Aptasensor for Glycated Albumin Detection
    Wassa Waiwinya, Thitirat Putnin, Dechnarong Pimalai, Wireeya Chawjiraphan, Nuankanya Sathirapongsasuti, Deanpen Japrung · 2021 · Biosensors
  6. Fructose and methylglyoxal-induced glycation alters structural and functional properties of salivary proteins, albumin and lysozyme
    Mariane Yumiko Muraoka, Allisson Benatti Justino, Douglas Carvalho Caixeta, Julia Silveira Queiroz, Robinson Sabino Silva, Foued Salmen Espíndola · 2022 · PLoS ONE
  7. Diabetes Management in the Kidney Patient
    Rajesh Garg, Mark E. Williams · 2013 · Medical Clinics of North America
  8. Defining the relationship between average glucose and HbA1c in patients with type 2 diabetes and chronic kidney disease
    Clement Lo, Michelle L. Lui, Sanjeeva Ranasinha, Helena Jane Teede, Peter G. Kerr, Kevan Roy Polkinghorne, David M. Nathan, Hui Zheng, Sophia Zoungas · 2014 · Diabetes Research and Clinical Practice
  9. The <scp>G</scp>lycemic <scp>I</scp>ndices in <scp>D</scp>ialysis <scp>E</scp>valuation (<scp>GIDE</scp>) study: Comparative measures of glycemic control in diabetic dialysis patients
    Williams, Mark E., Mittman, Neal, Ma, Lin, Brennan, Julia I., Mooney, Ann, Johnson, Curtis D., Jani, Chinu M., Maddux, Franklin W., Lacson, Eduardo · 2015 · Hemodialysis International
  10. Reducing Cardiometabolic Risk in Peritoneal Dialysis Patients: Role of the Dialysis Solution
    Cliff J. Holmes · 2009 · Journal of Diabetes Science and Technology
  11. Use of Glucose-Lowering Agents in Diabetes and CKD
    Radica Z. Alicic, Joshua J. Neumiller, Rodolfo Javier Galindo, Katherine R. Tuttle · 2022 · Kidney International Reports
  12. A newer conversion equation for the correlation between HbA1c and glycated albumin
    Kaori Inoue, Tetsuro Tsujimoto, Ritsuko Yamamoto‐Honda, Atsushi Goto, Miyako Kishimoto, Hiroshi Noto, Hiroshi Kajio, Seiichi Doi, Sumio Miyazaki, Yasuo Terauchi et al. · 2014 · Endocrine Journal
  13. Glycated Albumin versus Glycated Hemoglobin as a Glycemic Indicator in Diabetic Patients on Peritoneal Dialysis
    Hiroki Hill Kobayashi, Masanori Abe, Yoshinori Yoshida, Hiroko Suzuki, Noriaki Maruyama, Kazuyoshi Okada · 2016 · International Journal of Molecular Sciences
  14. Is there a “burnt-out diabetes” phenomenon in patients on hemodialysis?
    Masanori Abe, Takayuki Hamano, Junichi Hoshino, Atsushi Wada, Masaaki Inaba, Shigeru Nakai, Ikuto Masakane · 2017 · Diabetes Research and Clinical Practice
  15. The clinical usefulness of glycated albumin in patients with diabetes and chronic kidney disease: Progress and challenges
    Ting Gan, Baoying Liao, Gaosi Xu · 2018 · Journal of Diabetes and its Complications
  16. Cardiorenal Syndrome Type 4—Cardiovascular Disease in Patients with Chronic Kidney Disease: Epidemiology, Pathogenesis, and Management
    Panagiotis Pateinakis, Aikaterini A. Papagianni · 2011 · International Journal of Nephrology
  17. Inpatient Glycemic Management in the Setting of Renal Insufficiency/Failure/Dialysis
    Ravi Iyengar, Jennifer Franzese, Roma Yogesh Gianchandani · 2018 · Current Diabetes Reports
  18. Combination therapy with mitiglinide and voglibose improves glycemic control in type 2 diabetic patients on hemodialysis
    Masanori Abe, Kazuyoshi Okada, Takashi Maruyama, Noriaki Maruyama, Koichí Matsumoto · 2009 · Expert Opinion on Pharmacotherapy
  19. Management of the Diabetic Patient with Advanced Chronic Kidney Disease
    Radica Z. Alicic, Katherine R. Tuttle · 2010 · Seminars in Dialysis
  20. Developing an HbA1c-Based Equation to Estimate Blood Glucose in Maintenance Hemodialysis Patients
    Junichi Hoshino, Miklos Zsolt Molnar, Kunihiro Yamagata, Yoshifumi Ubara, Kenmei Takaichi, Csaba Pal Kovesdy, Kamyar Kalantar‐Zadeh · 2012 · Diabetes Care
  21. Association of HbA1c Values with Mortality and Cardiovascular Events in Diabetic Dialysis Patients. The INVOR Study and Review of the Literature
    Gisela Sturm, Claudia Lamina, Emanuel Zitt, Karl Lhotta, Florian Haider, Ulrich Neyer, Florian Kronenberg · 2011 · PLoS ONE
  22. Use of Continuous Glucose Monitoring in Patients with Diabetes Mellitus on Peritoneal Dialysis: Correlation with Glycated Hemoglobin and Detection of High Incidence of Unaware Hypoglycemia
    Ahad Qayyum, Tahseen Ahmad Chowdhury, Elizabeth Ley Oei, Stanley L. Fan · 2015 · Blood Purification
  23. The relationship between advanced glycation end products and ocular circulation in type 2 diabetes
    Kazuki Hashimoto, Hiroshi Kunikata, Masayuki Yasuda, Azusa Ito, Naoko Aizawa, Shojiro Sawada, Keiichi Kondo, Chihiro Satake, Yoshimasa Takano, Koji M. Nishiguchi et al. · 2016 · Journal of Diabetes and its Complications
  24. An improved enzymatic assay for glycated serum protein
    Dewi Abidin, Limin Liu, Chao Ran Dou, Abhijit Datta, Chong Yuan · 2013 · Analytical Methods
  25. Using Hemoglobin A1c to Derive Mean Blood Glucose in Peritoneal Dialysis Patients
    Junichi Hoshino, Rajnish Mehrotra, Connie M. Rhee, Kunihiro Yamagata, Yoshifumi Ubara, Kenmei Takaichi, Csaba Pal Kovesdy, Miklos Zsolt Molnar, Kamyar Kalantar‐Zadeh · 2013 · American Journal of Nephrology
  26. Extremes of Glycemic Control (HbA1c) Increase Hospitalization Risk in Diabetic Hemodialysis Patients in the USA
    M.E. Williams, Eduardo Lacson, Ming Foey Teng, Raymond M. Hakim, J. Michael Lazarus · 2008 · American Journal of Nephrology
  27. Glycated albumin levels are higher relative to glycated haemoglobin levels in gastrectomized subjects
    Masafumi Koga, Jun Murai, Hiroshi Saito, Mikio Mukai, Soeko Matsumoto, Soji Kasayama · 2009 · Annals of Clinical Biochemistry International Journal of Laboratory Medicine
  28. Recommendations for self-monitoring in pediatric diabetes: a consensus statement by the ISPED
    Diabetes Study Group of the Italian Society for Pediatric Endocrinology and Diabetology, Andrea E. Scaramuzza, Valentino Cherubini, Stefano Tumini, Riccardo Bonfanti, Pietro Buono, Francesca Cardella, Giuseppe d’Annunzio, Anna Paola Frongia, Fortunato Lombardo et al. · 2013 · Acta Diabetologica
  29. Effect of renal function on serum concentration of 1,5‐anhydroglucitol in type 2 diabetic patients in chronic kidney disease stages I–III: A comparative study with HbA1c and glycated albumin
    Christoph Hasslacher, Felix Kulozik · 2015 · Journal of Diabetes
  30. Vildagliptin is Effective for Glycemic Control in Diabetic Patients Undergoing either Hemodialysis or Peritoneal Dialysis
    Hiroyuki Ito, Mizuo Mifune, Eriko Matsuyama, Masahide Furusho, Takashi Omoto, Masahiro Shinozaki, Shinya Nishio, Shinichi Antoku, Mariko Abe, Michiko Togane et al. · 2013 · Diabetes Therapy
  31. The impact of sickle cell trait on glycated haemoglobin in diabetes mellitus
    Anthony J. Bleyer, S. Vidya, Leon Sujata, Gregory B. Russell, Damilola Akinnifesi, Donald Hire, Zak K. Shihabi, Mary Ann Knovich, Pirouz Daeihagh, Jorge Calles et al. · 2010 · Diabetic Medicine
  32. Relationship between Glycosylated Hemoglobin and Blood Glucose during Progression of Chronic Kidney Disease
    Rajiv Agarwal, Robert P. Light · 2011 · American Journal of Nephrology
  33. Influence of Variables on Hemoglobin A1c Values and Nonheterogeneity of Hemoglobin A1c Reference Ranges
    Trefor Higgins, George S. Cembrowski, David V. Tran, Erin Lim, Julie Chan · 2009 · Journal of Diabetes Science and Technology
  34. What is the Role of HbA1c in Diabetic Hemodialysis Patients?
    Sílvia Coelho · 2015 · Seminars in Dialysis
  35. Serum albumin-adjusted glycated albumin reflects glycemic excursion in diabetic patients with severe chronic kidney disease not treated with dialysis
    Kei Fukami, Ryo Shibata, Hitomi Nakayama, Kentaro Yamada, Seiya Okuda, Masafumi Koga · 2015 · Journal of Diabetes and its Complications
  36. Calorimetric investigation of diclofenac drug binding to a panel of moderately glycated serum albumins
    Venkata S.K. Indurthi, Estelle Leclerc, Stefan W. Vetter · 2014 · European Journal of Pharmaceutical Sciences
  37. Increased risk of cardiovascular mortality by strict glycemic control (pre-procedural HbA1c < 6.5%) in Japanese medically-treated diabetic patients following percutaneous coronary intervention: a 10-year follow-up study
    Takehiro Funamizu, Hiroshi Iwata, Yuya Nishida, Katsutoshi Miyosawa, Shinichiro Doi, Yuichi Chikata, Jun Shitara, Hirohisa Endo, Hideki Wada, Ryo Naito et al. · 2020 · Cardiovascular Diabetology
  38. Glycated albumin is a more accurate glycaemic indicator than haemoglobin A1c in diabetic patients with pre‐dialysis chronic kidney disease
    Il Young Kim, Min Jung Kim, Dong Won Lee, Soo Bong Lee, Harin Rhee, Sang Heon Song, Eun Young Seong, Ihm Soo Kwak · 2015 · Nephrology
  39. Clinical usefulness of the measurement of serum fructosamine in childhood diabetes mellitus
    Dong Soo Kang, Jiyun Park, Jae Kyung Kim, Jeesuk Yu · 2015 · Annals of Pediatric Endocrinology & Metabolism
  40. Continuous Glucose Monitoring Metrics in the Assessment of Glycemia in Moderate-to-Advanced CKD in Diabetes
    James Ling, Jack Kit‐Chung Ng, Eric S. H. Lau, Ronald C.W., Alice P.S. Kong, Andrea O. Y. Luk, Jeffrey Sung-Shing Kwok, Cheuk‐Chun Szeto, Juliana C.N. Chan, Elaine Chow · 2022 · Kidney International Reports
  41. Usefulness of glycated albumin as a biomarker for glucose control and prognostic factor in chronic kidney disease patients on dialysis (CKD-G5D)
    Elena Dozio, Valentina Corradi, Marta Proglio, Elena Vianello, Lorenzo Menicanti, Roberta Rigolini, Carlotta Caprara, Massimo de Cal, Massimiliano Marco Corsi Romanelli, Claudio Ronco · 2018 · Diabetes Research and Clinical Practice
  42. Comparative analysis of lipid and glucose metabolism biomarkers in non-diabetic hemodialysis and peritoneal dialysis patients
    Thyago Proença de Moraes, Paulo Cezar Nunes Fortes, Silvia Carreira Ribeiro, Miguel Carlos RIELLA, Roberto Pecoits‐Filho · 2011 · Brazilian Journal of Nephrology
  43. New‐Onset Diabetes Mellitus in Peritoneal Dialysis and Hemodialysis Patients: Frequency, Risk Factors, and Prognosis—A Review
    Rajashri Yarragudi, Alois Gessl, Andreas Vychytil · 2019 · Therapeutic Apheresis and Dialysis
  44. Current therapeutic approaches in the management of hyperglycemia in chronic renal disease
    Vishnu Vardhan Garla, Licy L Yanes-Cardozo, Lillian F. Lien · 2017 · Reviews in Endocrine and Metabolic Disorders
  45. Comparison of HbA1c and glycated albumin as a control marker for newborn complications in diabetic women in a multicentre study in Japan (Japan glycated albumin study group: study 2)
    Ikki Shimizu, Yuji Hiramatsu, Yasue Omori, Masao Nakabayashi, the JGA (Japan Glycated Albumin) Study Group · 2018 · Annals of Clinical Biochemistry International Journal of Laboratory Medicine
  46. The agreement between fasting glucose and markers of chronic glycaemic exposure in individuals with and without chronic kidney disease: a cross-sectional study
    Cindy George, Tandi Edith Matsha, Marizna Korf, Annalise E. Zemlin, Rajiv Timothy Erasmus, André Pascal Kengne · 2020 · BMC Nephrology
  47. Serum albumin-adjusted glycated albumin as a better indicator of glycemic control in Type 2 diabetes mellitus patients with short duration of hemodialysis
    Takahiro Yajima, Kumiko Yajima, Makoto Hayashi, Hiroshi Takahashi, Keigo Yasuda · 2017 · Diabetes Research and Clinical Practice
  48. Integrating Bayesian Approaches and Expert Knowledge for Forecasting Continuous Glucose Monitoring Values in Type 2 Diabetes Mellitus
    Yuyang Sun, Panagiotis Kosmas · 2024 · IEEE Journal of Biomedical and Health Informatics
  49. Influence of Age and Nutritional Status on Glycated Albumin Values in Hemodialysis Patients
    Tomonari Okada, Toshiyuki Nakao, Hiroshi Matsumoto, Tamami Yamanaka, Yume Nagaoka, Tokiyo Tamekuni · 2009 · Internal Medicine
  50. Serum glycated albumin, but not glycated hemoglobin, is low in relation to glycemia in men with hypertriglyceridemia
    Masafumi Koga, Jun Murai, Hiroshi Saito, Mikio Mukai, Soji Kasayama · 2010 · Journal of Diabetes Investigation
  51. Evaluation of the glycated albumin/HbA1c ratio by stage of diabetic nephropathy
    Masafumi Koga, Jun Murai, Hiroshi Saito, Michio Otsuki, Soji Kasayama · 2011 · Diabetology International
  52. Comparative study on hemoglobin A1c, glycated albumin and glycosylated serum protein in aplastic anemia patients with Type 2 diabetes mellitus
    Minghuan Suo, Dongmei Wen, Weijia Wang, Tingting Zhang · 2020 · Bioscience Reports
  53. Glycated Albumin in Patients with Neonatal Diabetes Mellitus Is Apparently Low in Relation to Glycemia Compared with That in Patients with Type 1 Diabetes Mellitus
    Shigeru Suzuki, Masafumi Koga, Hironori Takahashi, Kumihiro Matsuo, Yusuke Tanahashi, Hiroshi Azuma · 2012 · Hormone Research in Paediatrics
  54. Serum albumin-adjusted glycated albumin is a better predictor of mortality in diabetic patients with end-stage renal disease on hemodialysis
    Takahiro Yajima, Kumiko Yajima, Makoto Hayashi, Keigo Yasuda, Hiroshi Takahashi, Noriyoshi Yamakita · 2016 · Journal of Diabetes and its Complications
  55. Glycated albumin may be a possible alternative to hemoglobin A1c in diabetic patients with anemia
    Sollip Kim, Won‐Ki Min, Sail Chun, Woochang Lee, Haeil Park · 2011 · Clinical Chemistry and Laboratory Medicine (CCLM)
  56. “Mind the gap please…”: estimated vs. measured A1c from continuous measurement of interstitial glucose over a 3-month period in patients with type 1 diabetes
    Philippe Oriot, Michel Paul Hermans · 2018 · Acta Clinica Belgica
  57. Estimating Average Glucose Levels from Glycated Albumin in Patients with End-Stage Renal Disease
    Jwa-Kyung Kim, Jung Tak Park, Hyung Jung Oh, Dong Eun Yoo, Seung Jun Kim, Seung Hyeok Han, Shin‐Wook Kang, Kyu Hun Choi, Tae‐Hyun Yoo · 2012 · Yonsei Medical Journal
  58. Detection of Glycated Albumin Using a Novel Field Effect Aptasensor
    Mahdi Sasar, Azad Farzadfard, Yaser Abdi, Mehran Habibi-Rezaei · 2020 · IEEE Sensors Journal
  59. Management of adults with diabetes on dialysis: Summary of recommendations of the Joint British Diabetes Societies guidelines 2022
    Andrew Frankel, Mona M. Wahba, Vicky Ashworth, Rachna Bedi, Rachel Berrington, Maria Buckley, Lakshmi Chandrasekharan, Fiona Doyle, Deborah Duval, Frances L. Game et al. · 2022 · Diabetic Medicine
  60. Prevalence of chronic kidney disease using estimated glomerular filtration rate among diabetes patients attending a tertiary clinic in Botswana
    Godfrey Mutashambara Rwegerera, Onkabetse Julia Molefe‐Baikai, Anthony Masaka, Meshack Shimwela, Yordanka Piña Rivera, Taibat Aderonke Oyewo, Brian Godman, Amos Yared Massele, Dereje Habte · 2018 · Hospital Practice
  61. Glycated albumin in chronic kidney disease: Pathophysiologic connections
    Alok Raghav, Jamal Ahmad · 2018 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
  62. Hemolysis causes a decrease in HbA1c level but not in glycated albumin or 1,5-anhydroglucitol level
    Nanami Kiniwa, Toshika Okumiya, Shinji Tokuhiro, Yoshihisa Matsumura, Hirotaka Matsui, Masafumi Koga · 2019 · Scandinavian Journal of Clinical and Laboratory Investigation
  63. Making sense of glucose sensors in end-stage kidney disease: A review
    Mark E. Williams, Devin Steenkamp, Howard A. Wolpert · 2022 · Frontiers in Clinical Diabetes and Healthcare
  64. Usefulness of Glycated Albumin Assay for Diabetes Monitoring
    Randie R. Little · 2011 · Journal of Diabetes Science and Technology
  65. Use of complementary markers in assessing glycaemic control in people with diabetic kidney disease undergoing iron or erythropoietin treatment
    Judit Konya, Jen M. Ng, Heidi Cox, Michelle Cooke, Noni L. Lewis, Sunil Bhandari, Stephen Lawrence Atkin, Eric S. Kilpatrick · 2013 · Diabetic Medicine
  66. Serum albumin-adjusted glycated albumin is a better indicator of glycaemic control in diabetic patients with end-stage renal disease not on haemodialysis
    Kei Fukami, Ryo Shibata, Hitomi Nakayama, Kentaro Yamada, Seiya Okuda, Masafumi Koga · 2015 · Annals of Clinical Biochemistry International Journal of Laboratory Medicine
  67. Challenges of Glycemic Control in People With Diabetes and Advanced Kidney Disease and the Potential of Automated Insulin Delivery
    Jean Lu, Petrova Lee, Francesco L. Ierino, Richard J. MacIsaac, Elif Ilhan Ekinci, David Norman O'Neal · 2023 · Journal of Diabetes Science and Technology
  68. In vitro determination of hemoglobin A1c for diabetes diagnosis and management: technology update
    Garry John, Emma English, Elise T. Milosevich · 2014 · Pathology and Laboratory Medicine International
  69. Effect of Baseline Glycemic Level on Long-Term Cardiovascular Outcomes After Coronary Revascularization Therapy in Patients With Type 2 Diabetes Mellitus Treated With Hypoglycemic Agents
    Natsuhiko Ehara, Takeshi Morimoto, Yutaka Furukawa, Satoshi Shizuta, Ryoji Taniguchi, Yoshihisa Nakagawa, Kozo Hoshino, Naritatsu Saito, Takahiro Doi, Yoshisumi Haruna et al. · 2010 · The American Journal of Cardiology
  70. Association of glycated albumin, but not glycated hemoglobin, with calcaneus quantitative ultrasound in male hemodialysis patients with type 2 diabetes mellitus
    Shinsuke Yamada, Masaaki Inaba, S Okada, Yasuo Imanishi, Katsuhito Mori, Masanori Emoto, Eiji Ishimura, Yoshiki Nishizawà · 2009 · Metabolism
  71. Monitoring Glycemic Control in End-Stage Renal Disease: What Should Be Measured?
    Elizabeth Selvin, David B. Sacks · 2016 · Clinical Chemistry
  72. Amadori products promote cellular senescence activating insulin-like growth factor-1 receptor and down-regulating the antioxidant enzyme catalase
    Maria Del Nogal Avila, Nuria Troyano, Pablo Román‐García, Jorge Benito Cannata-Andía, Manuel Rodrı́guez-Puyol, Diego Rodrı́guez-Puyol, Makoto Kuro‐o, María Piedad Ruiz‐Torres · 2013 · The International Journal of Biochemistry & Cell Biology
  73. Glycated albumin is a better indicator of the glucose excursion than predialysis glucose and hemoglobin A1c in hemodialysis patients
    Yuki Tsuruta, Akiko Ichikawa, Kan Kikuchi, Yoshihisa Echida, Takako Onuki, Kosaku Nitta · 2016 · Renal Replacement Therapy
  74. Linagliptin monotherapy compared with voglibose monotherapy in patients with type 2 diabetes undergoing hemodialysis: a 12-week randomized trial
    Katsuhito Mori, Masanori Emoto, Tetsuo Shoji, Masaaki Inaba · 2016 · BMJ Open Diabetes Research & Care
  75. Glycated albumin and the risk of chronic kidney disease in subjects with Type 2 Diabetes: A study in North Indian Population
    Alok Raghav, Jamal Ahmad, Saba Noor, Khursheed Alam, Brijesh Kumar Mishra · 2018 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
  76. The Effect of Glycated Hemoglobin and Albumin-Corrected Glycated Serum Protein on Mortality in Diabetic Patients Receiving Continuous Peritoneal Dialysis
    Fenfen Peng, Xi Xia, Feng He, Zhijian Li, Fengxian Huang, Xueqing Yu · 2014 · Peritoneal Dialysis International
  77. Levels of glycated albumin at different stages of diabetic nephropathy in India
    Vijay Viswanathan, Satyavani Kumpatla, Priyanka Tilak P., Parthiban Muthukumaran · 2019 · International Journal of Diabetes and Metabolism
  78. Dapsone interferes with hemoglobin A1c monitoring of diabetes in an HIV-infected patient
    Alison C. Roxby, Rupali Jain · 2012 · AIDS
  79. Use of continuous glucose monitoring in patients with diabetes on peritoneal dialysis: poor correlation with HbA1c and high incidence of hypoglycaemia
    Elizabeth Ley Oei, Nasreen Samad, A. Visser, Tahseen Ahmad Chowdhury, Stanley Fan · 2015 · Diabetic Medicine
  80. Changes in antidiabetic prescription patterns and indicators of diabetic control among 200,000 patients over 13 years at a single institution in Japan
    Kazutoshi Fujibayashi, Michio Hayashi, Hirohide Yokokawa, Toshio Naito · 2016 · Diabetology & Metabolic Syndrome
  81. Blood glucose levels in peritoneal dialysis are better reflected by HbA1c than by glycated albumin.
    Yusuke Watanabe, Yoichi Ohno, Tsutomu Inoue, Hiroshi Takane, Hirokazu Okada, Hiromichi Suzuki · 2014 · PubMed
  82. Utilising continuous glucose monitoring for glycemic control in diabetic kidney disease
    Vamsidhar Veeranki, Narayan Prasad · 2024 · World Journal of Diabetes
  83. Critical discrepancy in blood glucose control levels evaluated by glycated albumin and estimated hemoglobin A1c levels determined from a flash continuous glucose monitoring system in patients with type 2 diabetes on hemodialysis
    Emi Ushigome, Seiko Matsusaki, Nami Watanabe, Tetsuya Hashimoto, Naoto Nakamura, Michiaki Fukui · 2020 · Journal of Diabetes Investigation
  84. Glycated Albumin for Glycemic Control in T2DM Population: A Multi-Dimensional Evaluation
    Lucrezia Bianca Ferrario, Fabrizio Schettini, Angelo Avogaro, Chiara Bellia, Federico Bertuzzi, Graziella Bonetti, Antonio Ceriello, Marcello Ciaccio, Massimiliano Marco Corsi Romanelli, Elena Dozio et al. · 2021 · ClinicoEconomics and Outcomes Research
  85. Global Epidemiology, Health Outcomes, and Treatment Options for Patients With Type 2 Diabetes and Kidney Failure
    Jessica Phillips, Jenny H. C. Chen, Esther M. M. Ooi, Janelle Prunster, Wai H. Lim · 2021 · Frontiers in Clinical Diabetes and Healthcare
  86. Glycated Albumin – More Than the Missing Link in the Evaluation of Diabetes Control
    Robert Dinu, Eugen Moța · 2014 · Romanian Journal of Diabetes Nutrition and Metabolic Diseases
  87. Evaluation of Aromatic Boronic Acids as Ligands for Measuring Diabetes Markers on Carbon Nanotube Field-Effect Transistors
    Steingrimur Stefansson, Lára A. Stefansson, Suk-won Chung, Kevin Ko, Hena H. Kwon, Saeyoung Nate Ahn · 2012 · Journal of Nanotechnology
  88. Carbohydrate Metabolism in Kidney Disease and Kidney Failure
    Eberhard Ritz, Marcin Adamczak, Andrzej Więcek · 2012 · Elsevier eBooks
  89. The Accuracy of Hemoglobin A1c and Fructosamine Evaluated by Long-Term Continuous Glucose Monitoring in Patients with Type 2 Diabetes Undergoing Hemodialysis
    Tobias Bomholt, Marianne Rix, Thomas Almdal, Filip Krag Knop, Susanne Rosthøj, Niels Søndergaard Heinrich, Morten Buus Jørgensen, Anders Olof Larsson, Linda Maria Hilsted, Bo Feldt‐Rasmussen et al. · 2021 · Blood Purification
  90. Glycated albumin is not significantly correlated with body mass index in patients with acute-onset type 1 diabetes
    Takumi Hirata, Masafumi Koga, Soji Kasayama, Jiro Morimoto, Taro Maruyama · 2014 · Clinica Chimica Acta
  91. Physiologic Concepts That May Revise the Interpretation and Implications of HbA1C in Clinical Medicine
    Eric P. Smith, Robert M. Cohen · 2015 · Journal of Diabetes Science and Technology
  92. Luminol-based electrochemiluminescent biosensors for highly sensitive medical diagnosis and rapid antioxidant detection
    Eiichi Tamiya, Yuki Inoue, Masato Saito · 2018 · Japanese Journal of Applied Physics
  93. Rate of the “burnt-out diabetes” phenomenon in patients on peritoneal dialysis
    Masanori Abe, Takayuki Hamano, Junichi Hoshino, Atsushi Wada, Shigeru Nakai, Ikuto Masakane · 2018 · Diabetes Research and Clinical Practice
  94. Glycated albumin level is significantly decreased in patients suffering nephrotic syndrome
    Zhe Wang, Guangqun Xing, Lijuan Zhang · 2019 · Progress in molecular biology and translational science
  95. Accuracy of Dexcom G6 Pro and G7 Continuous Glucose Monitors in Patients Treated with Maintenance Dialysis
    Leila R. Zelnick, Subbulaxmi Trikudanathan, Yoshio N. Hall, Ernest Ayers, Lisa Anderson, Nathaniel K. Ashford, Evelin Jones, Andrew N. Hoofnagle, Ian H. de Boer, Irl B. Hirsch · 2025 · Diabetes Technology & Therapeutics
  96. Associations of Glycated Albumin and HbA1c with Chronic Kidney Disease in US Adults
    Hyunju Kim, Olive Tang, Casey M. Rebholz, Morgan Erika Grams, Josef Coresh, Robert H. Christenson, Elizabeth Selvin · 2022 · The Journal of Applied Laboratory Medicine
  97. Toward Revision of the ‘Best Practice for Diabetic Patients on Hemodialysis 2012’
    Masanori Abe, Tomomi Matsuoka, Shunsuke Kawamoto, Kota Miyasato, Hiroki Hill Kobayashi · 2022 · Kidney and Dialysis
  98. Assessing Glycemic Control in Diabetic Patients With Severe Nephropathy
    Todd W. Robinson, Barry I. Freedman · 2013 · Journal of Renal Nutrition
  99. Association of oral calcitriol with improved survival in non-dialysed and dialysed patients with CKD
    Armando Luis Negri · 2008 · Nephrology Dialysis Transplantation
  100. Glycated albumin and HbA1c as predictors of mortality and vascular complications in type 2 diabetes patients with normal and moderately impaired renal function: 5-year results from a 380 patient cohort
    Christoph Hasslacher, Felix Kulozik, Isabel Platten, Justo Lorenzo Bermejo · 2014 · journal of Diabetes Research and Clinical Metabolism